Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.
暂无分享,去创建一个
A Seller | A H Schapira | S. Tabrizi | P. Styles | A. Seller | R. Lodi | D. Taylor | A. Schapira | A. Schapira | D J Taylor | D. Hilton‐Jones | P Styles | M. Squier | R Lodi | S J Tabrizi | D Hilton-Jones | M V Squier | D. Taylor | Aneke Seller
[1] S. Dimauro,et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region , 1989, Nature.
[2] D. Gadian,et al. Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. , 1983, Molecular biology & medicine.
[3] S. Dimauro,et al. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients , 1996, Annals of neurology.
[4] G. Radda,et al. Bioenergetics of skeletal muscle in mitochondrial myopathy , 1994, Journal of the Neurological Sciences.
[5] A. Pestronk,et al. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. , 1997, Brain : a journal of neurology.
[6] E. Holme,et al. Mitochondrial DNA Deletions in Muscle Fibers in Inclusion Body Myositis , 1995, Journal of neuropathology and experimental neurology.
[7] P. Matthews,et al. metabolic recovery after exercise and the assessment of mitochondrial function in Vivo in human skeletal muscle by means of 31P NMR , 1984, Magnetic resonance in medicine.
[8] Franca Podo,et al. Magnetic resonance spectroscopy in biology and medicine : functional and pathological tissue characterization , 1992 .
[9] B CHANCE,et al. Respiratory enzymes in oxidative phosphorylation. III. The steady state. , 1955, The Journal of biological chemistry.
[10] A. Eisen,et al. Inclusion body myositis , 1978, Neurology.
[11] M. Dalakas,et al. Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis , 1997, Neurology.
[12] J. Müller‐Höcker. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: An age-related alteration , 1990, Journal of the Neurological Sciences.
[13] S. Dimauro,et al. Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. , 1992, Biochimica et biophysica acta.
[14] Simon C Watkins,et al. A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis , 1987, Journal of the Neurological Sciences.
[15] G K Radda,et al. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle , 1993, NMR in biomedicine.
[16] H A Krebs,et al. Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.
[17] P. Matthews,et al. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondria1 disease , 1991, Neurology.
[18] E. Holme,et al. Mitochondrial DNA deletions in inclusion body myositis. , 1993, Brain : a journal of neurology.
[19] J. Dambrosia,et al. Treatment of inclusion-body myositis with IVIg , 1997, Neurology.
[20] S. Carpenter,et al. Pathology of Skeletal Muscle , 1984 .
[21] S. Dimauro,et al. Inclusion body myositis and myopathies , 1995, Annals of neurology.
[22] P. M. Matthews,et al. Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders , 1995, Neurology.
[23] S. Welle,et al. Ragged Red Fibers in Normal Aging and Inflammatory Myopathy , 1995, Annals of neurology.
[24] S. Frostick,et al. Cellular energetics of dystrophic muscle , 1993, Journal of the Neurological Sciences.
[25] G Serratrice,et al. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies , 1992, Neurology.
[26] M. Lazdunski,et al. The regulation of the intracellular pH in cells from vertebrates. , 1988, European journal of biochemistry.
[27] D. Arnold,et al. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy , 1985, Annals of neurology.
[28] L. Salberg,et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 1994, Neurology.
[29] J. Masdeu,et al. Inclusion body myositis. A corticosteroid-resistant idiopathic inflammatory myopathy. , 1982, Archives of neurology.
[30] J. Durnin,et al. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years , 1974, British Journal of Nutrition.
[31] G. Radda,et al. In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy , 1997, Annals of neurology.
[32] N. Bresolin,et al. Leber's hereditary optic neuropathy , 1991, Neurology.
[33] M. Dalakas,et al. Inclusion Body Myositis , 1997, Neurology.
[34] B CHANCE,et al. Respiratory enzymes in oxidative phosphorylation. II. Difference spectra. , 1955, The Journal of biological chemistry.
[35] C. Hengstenberg,et al. Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy. , 1995, Biochemical and biophysical research communications.